Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid

Journal of Biomedical Materials Research - Part A

Volumn 98 A, Issue 3, 2011, Pages 394-403

  De Haan, Bart J ^a   Rossi, Alessandra ^b   Faas, Marijke M ^a   Smelt, Maaike J ^a   Sonvico, Fabio ^b   Colombo, Paolo ^b   De Vos, Paul ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

alginate; inflammation; microencapsulation; surface analysis

Indexed keywords

ALGINATE-BASED MICROCAPSULES; CAPSULE SURFACES; CLINICAL APPLICATION; HUMAN PERIPHERAL BLOOD; IMPLANTATION SITES; IN-VIVO; INFLAMMATION; INFLAMMATORY RESPONSE; MICROCAPSULES; MICROENCAPSULATION; PERITONEAL FLUID; PHYSICO-CHEMICAL CHANGES; STRUCTURAL SURFACES; TRANSFORM INFRARED SPECTROSCOPY;

ADSORPTION; AMINO ACIDS; BIOCOMPATIBILITY; ENCAPSULATION; FLUIDS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; PACKAGING; SURFACE ANALYSIS;

ALGINATE;

ALGINIC ACID; INTERLEUKIN 6; POLYLYSINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; INFLAMMATION; INFRARED SPECTROSCOPY; MICROENCAPSULATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEAL FLUID; PHYSICAL CHEMISTRY;

ADSORPTION; ALGINATES; ASCITIC FLUID; CAPSULES; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; LEUKOCYTES, MONONUCLEAR; POLYLYSINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960371481     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33123     Document Type: Article

References (62)

1. Chang PL, Shen N, Westcott AJ,. Delivery of recombinant gene products with microencapsulated cells in vivo. Hum Gene Ther 1993; 4: 433-440. (Pubitemid 24308311)
2. Liu HW, Ofosu FA, Chang PL,. Expression of human factor IX by microencapsulated recombinant fibroblasts. Hum Gene Ther 1993; 4: 291-301. (Pubitemid 23209562)
3. Cieslinski DA, Humes HD,. Tissue engineering of a bioartificial kidney. Biotechnol Bioeng 1994; 43: 678-681. (Pubitemid 24090715)
4. Wong H, Chang TM,. Bioartificial liver: Implanted artificial cells microencapsulated living hepatocytes increases survival of liver failure rats. Int J Artif Organs 1986; 9: 335-336. (Pubitemid 17213373)
5. Aebischer P, Russell PC, Christenson L, Panol G, Monchik JM, Galletti PM,. A bioartificial parathyroid. ASAIO Trans 1986; 32: 134-137.
6. Aebischer P, Goddard M, Signore AP, Timpson RL,. Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells. Exp Neurol 1994; 126: 151-158. (Pubitemid 24182036)
7. Lim F, Sun AM,. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908-910. (Pubitemid 11169847)
8. De Vos P, De Haan BJ, Wolters GHJ, Strubbe JH, Van Schilfgaarde R,. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 1997; 40: 262-270. (Pubitemid 27096549)
9. De Vos P, van Straaten JF, Nieuwenhuizen AG, de Groot M, Ploeg RJ, De Haan BJ, Van Schilfgaarde R,. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes 1999; 48: 1381-1388. (Pubitemid 29297299)
10. Koo J, Chang TSM,. Secretion of erythropoietin from microencapsulated rat kidney cells. Int J Artif Organs 1993; 16: 557-560. (Pubitemid 23272976)
11. De Vos P, Bucko M, Gemeiner P, Navratil M, Svitel J, Faas M, Strand BL, Skjak-Braek G, Morch YA, Vikartovska A, Lacik I, Kollarikova G, Orive G, Poncelet D, Pedraz JL, Ansorge-Schumacher MB,. Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 2009; 30: 2559-2570.
12. De Vos P, Faas MM, Strand B, Calafiore R,. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 2006; 27: 5603-5617. (Pubitemid 44177795)
13. Wang T, Adcock J, Kuhtreiber W, Qiang D, Salleng KJ, Trenary I, Williams P,. Successful allotransplantation of encapsulated islets in pancreatectomized canines for diabetic management without the use of immunosuppression. Transplantation 2008; 85: 331-337. (Pubitemid 351322755)
14. Qi M, Strand BL, Morch Y, Lacik I, Wang Y, Salehi P, Barbaro B, Gangemi A, Kuechle J, Romagnoli T, Hansen MA, Rodriguez LA, Benedetti E, Hunkeler D, Skjak-Braek G, Oberholzer J,. Encapsulation of human islets in novel inhomogeneous alginate-ca2+/ba2+ microbeads: In vitro and in vivo function. Artif Cells Blood Substit Immobil Biotechnol 2008; 36: 403-420.
15. Liu XY, Nothias JM, Scavone A, Garfinkel M, Millis JM,. Biocompatibility investigation of polyethylene glycol and alginate-poly- L -lysine for islet encapsulation. ASAIO J 2010; 56: 241-245.
16. Bunger CM, Gerlach C, Freier T, Schmitz KP, Pilz M, Werner C, Jonas L, Schareck W, Hopt UT, De Vos P,. Biocompatibility and surface structure of chemically modified immunoisolating alginate-PLL capsules. J Biomed Mater Res 2003; 67A: 1219-1227. (Pubitemid 37522735)
17. De Vos P, De Haan BJ, Kamps JA, Faas MM, Kitano T,. Zeta-potentials of alginate-PLL capsules: A predictive measure for biocompatibility? J Biomed Mater Res A 2007; 80: 813-819.
18. Tam SK, De Haan BJ, Faas MM, Halle JP, Yahia L, de VP,. Adsorption of human immunoglobulin to implantable alginate-poly- L -lysine microcapsules: Effect of microcapsule composition. J Biomed Mater Res A 2009; 89: 609-615.
19. De Vos P, Van Hoogmoed CG, van Zanten J, Netter S, Strubbe JH, Busscher HJ,. Long-term biocompatibility, chemistry, and function of microencapsulated pancreatic islets. Biomaterials 2003; 24: 305-312. (Pubitemid 35292574)
20. De Vos P, Van Hoogmoed CG, De Haan BJ, Busscher HJ,. Tissue responses against immunoisolating alginate-PLL capsules in the immediate posttransplant period. J Biomed Mater Res 2002; 62: 430-437. (Pubitemid 35332207)
21. De Vos P, Van Hoogmoed CG, Busscher HJ,. Chemistry and biocompatibility of alginate-PLL capsules for immunoprotection of mammalian cells. J Biomed Mater Res 2002; 60: 252-259. (Pubitemid 34194586)
22. Van Hoogmoed CG, Busscher HJ, De Vos P,. Fourier transform infrared spectroscopy studies of alginate-PLL capsules with varying compositions. J Biomed Mater Res A 2003; 67: 172-178. (Pubitemid 37517166)
23. Tam SK, Dusseault J, Polizu S, Menard M, Halle JP, Yahia L,. Physicochemical model of alginate-poly- L -lysine microcapsules defined at the micrometric/nanometric scale using ATR-FTIR, XPS, and ToF-SIMS. Biomaterials 2005; 26: 6950-6961. (Pubitemid 41095519)
24. Thanos CG, Bintz BE, Bell WJ, Qian H, Schneider PA, MacArthur DH, Emerich DF,. Intraperitoneal stability of alginate-polyornithine microcapsules in rats: An FTIR and SEM analysis. Biomaterials 2006; 27: 3570-3579.
25. Ferreira AP, Almeida AJ,. Cross-linked alginate-gelatine beads: A new matrix for controlled release of pindolol. J Control Release 2004; 97: 431-439. (Pubitemid 38802945)
26. Haug A, Larsen B,. The solibility of alginate at low pH. Acta Chem Scand 1963; 17: 1653-1662.
27. Staub AM,. Removal of proteins. In:, Whistler RL, Bemiller JN, Wolfrom ML, editors. Methods in Carbohydrate Chemistry. New York: Academic Press; 1965. p 163-168.
28. Haug A,. Alginic acid. Isolation and fractionation with potassium chloride and manganous ions. In:, Whistler RL, Bemiller JN, Wolfron ML, editors. Methods in Carbohydrate Chemistry. New York: Academic Press; 1965. p 69-72.
29. Haug A, Myklestad S, Larsen B, Smidsrod O,. Correlation between chemical structure and physical properties of alginates. Acta Chem Scand 1967; 21: 768-778.
30. De Vos P, De Haan B, Van Schilfgaarde R,. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials 1997; 18: 273-278. (Pubitemid 27064804)
31. Ponce S, Orive G, Hernandez R, Gascon AR, Pedraz JL, De Haan BJ, Faas MM, Mathieu HJ, De Vos P,. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition. Biomaterials 2006; 27: 4831-4839. (Pubitemid 43884839)
32. De Vos P, De Haan BJ, Van Schilfgaarde R,. Upscaling the production of encapsulated islets. Biomaterials 1997; 18: 1085-1090.
33. Veenstra van Nieuwenhoven AL, Bouman A, Moes H, Heineman MJ, de Leij LF, Santema J, Faas MM,. Endotoxin-induced cytokine production of monocytes of third-trimester pregnant women compared with women in the follicular phase of the menstrual cycle. Am J Obstet Gynecol 2003; 188: 1073-1077. (Pubitemid 36530066)
34. Faas MM, Bouman A, Veenstra van Nieuwenhoven AL, van der SG, Moes H, Heineman MJ, de VP,. Species differences in the effect of pregnancy on lymphocyte cytokine production between human and rat. J Leukoc Biol 2005; 78: 946-953. (Pubitemid 41384411)
35. Babensee JE, Cornelius RM, Brash JL, Sefton MV,. Immunoblot analysis of proteins associated with HEMA-MMA microcapsules: Human serum proteins in vitro and rat proteins following implantation. Biomaterials 1998; 19: 839-849. (Pubitemid 28276635)
36. Mosqueira VC, Legrand P, Gulik A, Bourdon O, Gref R, Labarre D, Barratt G,. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials 2001; 22: 2967-2979. (Pubitemid 32768704)
37. Zheng JN, Xie HG, Yu WT, Liu XD, Xie WY, Zhu J, Ma XJ,. Chitosan-g-MPEG-modified alginate/chitosan hydrogel microcapsules: A quantitative study of the effect of polymer architecture on the resistance to protein adsorption. Langmuir 2010; 26: 17156-17164.
38. Farrell M, Beaudoin S,. Surface forces and protein adsorption on dextran- and polyethylene glycol-modified polydimethylsiloxane. Colloids Surf B Biointerfaces 2010; 81: 468-475.
39. Kizhakkedathu JN, Janzen J, Le Y, Kainthan RK, Brooks DE,. Poly(oligo(ethylene glycol)acrylamide) brushes by surface initiated polymerization: Effect of macromonomer chain length on brush growth and protein adsorption from blood plasma. Langmuir 2009; 25: 3794-3801.
40. Wilflingseder J, Perco P, Kainz A, Korbely R, Mayer B, Oberbauer R,. Biocompatibility of haemodialysis membranes determined by gene expression of human leucocytes: A crossover study. Eur J Clin Invest 2008; 38: 918-924.
41. Treves C, Martinesi M, Stio M, Gutierrez A, Jimenez JA, Lopez MF,. In vitro biocompatibility evaluation of surface-modified titanium alloys. J Biomed Mater Res A 2010; 92: 1623-1634.
42. Pattani A, Patravale VB, Panicker L, Potdar PD,. Immunological effects and membrane interactions of chitosan nanoparticles. Mol Pharm 2009; 6: 345-352.
43. Andreoli MC, Dalboni MA, Watanabe R, Manfredi SR, Canziani ME, Kallas EG, Sesso RC, Draibe SA, Balakrishnan VS, Jaber BL, Liangos O, Cendoroglo M,. Impact of dialyzer membrane on apoptosis and function of polymorphonuclear cells and cytokine synthesis by peripheral blood mononuclear cells in hemodialysis patients. Artif Organs 2007; 31: 887-892. (Pubitemid 350173651)
44. Prymak O, Bogdanski D, Koller M, Esenwein SA, Muhr G, Beckmann F, Donath T, Assad M, Epple M,. Morphological characterization and in vitro biocompatibility of a porous nickel-titanium alloy. Biomaterials 2005; 26: 5801-5807. (Pubitemid 40798271)
45. Vandenbossche GMR, Bracke ME, Cuvelier CA, Bortier HE, Mareel AA, Remon JP,. Host reaction against empty alginate-polylysine microcapsules. (i) Influence of preparation procedure. J Pharm Pharmacol 1993; 2: 115-120. (Pubitemid 23081888)
46. Geisen K, Deutschländer H, Gorbach S, Klenke C, Zimmerman U. Function of barium alginate-microencapsulated xenogenic islets in different diabetic mouse models. In:, Shafrir E, editor. Frontiers in Diabetes Research. Lessons from Animal Diabetes III. Smith-Gordon; 1990. p 142-148.
47. Safley SA, Cui H, Cauffiel S, Tucker-Burden C, Weber CJ,. Biocompatibility and immune acceptance of adult porcine islets transplanted intraperitoneally in diabetic NOD mice in calcium alginate poly- L -lysine microcapsules versus barium alginate microcapsules without poly- L -lysine. J Diabetes Sci Technol 2008; 2: 760-767.
48. Ponce S, Orive G, Hernandez RM, Gascon AR, Canals JM, Munoz MT, Pedraz JL,. In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules. J Control Release 2006; 116: 28-34. (Pubitemid 44792297)
49. Ponce S, Orive G, Hernandez R, Gascon AR, Pedraz JL, De Haan BJ, Faas MM, Mathieu HJ, de VP,. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition. Biomaterials 2006; 27: 4831-4839. (Pubitemid 43884839)
50. Juste S, Lessard M, Henley N, Menard M, Halle JP,. Effect of poly- L -lysine coating on macrophage activation by alginate-based microcapsules: Assessment using a new in vitro method. J Biomed Mater Res A 2005; 72: 389-398. (Pubitemid 40315853)
51. King A, Strand B, Rokstad AM, Kulseng B, Andersson A, Skjak-Braek G, Sandler S,. Improvement of the biocompatibility of alginate/poly- L -lysine/alginate microcapsules by the use of epimerized alginate as a coating. J Biomed Mater Res A 2003; 64: 533-539. (Pubitemid 37522494)
52. Strand BL, Morch YA, Espevik T, Skjak-Braek G,. Visualization of alginate-poly- L -lysine-alginate microcapsules by confocal laser scanning microscopy. Biotechnol Bioeng 2003; 82: 386-394. (Pubitemid 36505876)
53. Thu B, Bruheim P, Espevik T, Smidrod O, Soon-Shiong P, Skjak-Braek G,. Alginate polycation microcapsules. I. Interaction between alginate and polycation. Biomaterials 1996; 17: 1031-1040. (Pubitemid 26160068)
54. Thu B, Bruheim P, Espevik T, Smidrod O, Soon-Shiong P, Skjak-Break G,. Alginate polycation microcapsules II. Some functional properties. Biomaterials 1996; 17: 1069-1079.
55. De Vos P, De Haan BJ, Pater J, Van Schilfgaarde R,. Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts. Transplantation 1996; 62: 893-899. (Pubitemid 26360347)
56. De Vos P, De Haan BJ, Wolters GHJ, Van Schilfgaarde R,. Factors influencing the adequacy of microencapsulation of rat pancreatic islets. Transplantation 1996; 62: 888-893. (Pubitemid 26360346)
57. De Vos P, Smedema I, van Goor H, Moes H, van Zanten J, Netters S, de Leij LF, de Haan A, De Haan BJ,. Association between macrophage activation and function of micro-encapsulated rat islets. Diabetologia 2003; 46: 666-673. (Pubitemid 36808186)
58. De Vos P, Andersson A, Tam SK, Faas MM, Halle JP,. Advances and barriers in mammalian cell encapsulation for treatment of Diabetes. Immun Endoc Metab Agents Med Chem 2006; 6: 139-153. (Pubitemid 43796735)
59. Dusseault J, Tam SK, Menard M, Polizu S, Jourdan G, Yahia L, Halle JP,. Evaluation of alginate purification methods: Effect on polyphenol, endotoxin, and protein contamination. J Biomed Mater Res A 2006; 76: 243-251.
60. Orive G, Tam SK, Pedraz JL, Halle JP,. Biocompatibility of alginate-poly- L -lysine microcapsules for cell therapy. Biomaterials 2006; 27: 3691-3700. (Pubitemid 43670522)
61. Robitaille R, Dusseault J, Henley N, Desbiens K, Labrecque N, Halle JP,. Inflammatory response to peritoneal implantation of alginate-poly- L -lysine microcapsules. Biomaterials 2005; 26: 4119-4127. (Pubitemid 40138658)
62. De Vos P, Bucko M, Gemeiner P, Navratil M, Svitel J, Faas M, Strand BL, Skjak-Braek G, Morch YA, Vikartovska A, Lacik I, Kollarikova G, Orive G, Poncelet D, Pedraz JL, nsorge-Schumacher MB,. Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 2009; 30: 2559-2570.